Breaking News Instant updates and real-time market news.

NUVA

NuVasive

$49.55

-0.96 (-1.90%)

16:30
02/08/19
02/08
16:30
02/08/19
16:30

Smith & Nephew in discussions to acquire NuVasive for over $3B, FT reports

Smith & Nephew has held talks to acquire NuVasive in a deal that would be worth more than $3B and mark the largest acquisition by the British medical devices group, FT reports, citing people with direct knowledge of the talks. Reference Link

  • 06

    Mar

NUVA NuVasive
$49.55

-0.96 (-1.90%)

01/07/19
PIPR
01/07/19
NO CHANGE
Target $70
PIPR
Overweight
NuVasive shares 'cheap' with 2019 looking brighter than Q4, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said he understand concerns about NuVasive's $6M Q4 revenue miss versus consensus, but he believes based on his view of the company's "innovative products" and year-end checks indicating that the spine market is improving that the company should see "a beat-and-raise dynamic" next year. NuVasive is "still a great earnings power story" and the shares looks "very cheap" on an EV/EBITDA basis, said O'Brien, who keeps an Overweight rating on the stock with a price target of $70.
01/17/19
BTIG
01/17/19
NO CHANGE
Target $59
BTIG
Buy
NuVasive price target lowered to $59 from $70 at BTIG
BTIG analyst Ryan Zimmerman lowered his price target on NuVasive to $59 after meeting with its CEO Chris Barry, saying that he was "upfront" about the company FY18 results and may take the opportunity to reset expectations entering FY19. The analyst also keeps his Buy rating on NuVasive shares, noting that its valuation is at a 3-year lows even though the company is looking to accelerate its potential robotic commercialization.
02/08/19
NEED
02/08/19
DOWNGRADE
NEED
Hold
NuVasive downgraded to Hold from Buy at Needham
02/08/19
NEED
02/08/19
DOWNGRADE
NEED
Hold
NuVasive downgraded to Hold from Buy at Needham
Needham analyst Mike Matson downgraded NuVasive to Hold to reflect the potential headwinds that the stock may experience from the company's expected revenue miss, reinvestment weight on margins, and the overall potential of slowing revenue growth. The analyst adds that NuVasive comps are set to become progressively more difficult starting in Q1 of FY19 and also warns that the company may "lose share to competitors with robots until it launches its own robot." Matson also lowers his FY19 EPS view to $2.46 from $2.52 and revenue to $1.15B from $1.17B.

TODAY'S FREE FLY STORIES

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

07:12
07/17/19
07/17
07:12
07/17/19
07:12
Conference/Events
Cardiovascular Systems management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:11
07/17/19
07/17
07:11
07/17/19
07:11
Hot Stocks
Vectura Group confirms R&D investment priorities »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

07:10
07/17/19
07/17
07:10
07/17/19
07:10
Recommendations
Wells Fargo analyst commentary  »

Wells Fargo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

VMW

VMware

$172.25

0.03 (0.02%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Recommendations
VMware analyst commentary  »

VMware estimates likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

SMMT

Summit Therapeutics

$1.35

-0.06 (-4.26%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Hot Stocks
Summit presents preclinical data on SMT-571 at STI & HIV World Congress »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHSI

Guardion Health Sciences

$0.97

-0.03 (-3.02%)

07:07
07/17/19
07/17
07:07
07/17/19
07:07
Hot Stocks
Guardion Health Sciences receives patent for MapcatSF in Hong Kong »

Guardion Health Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

07:06
07/17/19
07/17
07:06
07/17/19
07:06
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PSTI

Pluristem

$0.57

0.0319 (5.87%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Hot Stocks
Pluristem, U.S. DoD to announce data from studies testing PLX-R18 »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$215.57

4.02 (1.90%)

, MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Recommendations
Goldman Sachs, Morgan Stanley analyst commentary  »

Goldman Sachs price…

GS

Goldman Sachs

$215.57

4.02 (1.90%)

MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Oct

ACIU

AC Immune

$5.62

0.1 (1.81%)

, LLY

Eli Lilly

$108.81

0.36 (0.33%)

07:04
07/17/19
07/17
07:04
07/17/19
07:04
Hot Stocks
AC Immune initiates Phase 1 study of ACI-3024 »

AC Immune SA (ACIU)…

ACIU

AC Immune

$5.62

0.1 (1.81%)

LLY

Eli Lilly

$108.81

0.36 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

ANIX

Anixa Biosciences

$4.14

-0.01 (-0.24%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Anixa Biosciences partnering with Cleveland Clinic for breast cancer vaccine »

Anixa Biosciences has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRKR

Bruker

$49.61

-0.02 (-0.04%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Bruker comments on block trade transaction »

Bruker has been advised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 17

    Jul

07:02
07/17/19
07/17
07:02
07/17/19
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 7/12 MBA Mortgage…

NCNA

NuCana

$9.80

-0.05 (-0.51%)

07:02
07/17/19
07/17
07:02
07/17/19
07:02
Hot Stocks
NuCana doses first patients in Phase I study of NUC-7738 »

NuCana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHOOF

Choom Holdings

$0.00

(0.00%)

07:02
07/17/19
07/17
07:02
07/17/19
07:02
Hot Stocks
Choom Holdings to acquire 19.9% equity interest of Coastal Green »

Choom is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

07:01
07/17/19
07/17
07:01
07/17/19
07:01
Hot Stocks
PNC Financial sees FY19 revenue up at higher end of low single digits vs. FY18 »

Sees average loans up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

07:00
07/17/19
07/17
07:00
07/17/19
07:00
Hot Stocks
PNC Financial sees Q3 NII 'stable' vs. Q2 »

Sees average loans up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

JLL

Jones Lang LaSalle

$140.29

0.83 (0.60%)

06:59
07/17/19
07/17
06:59
07/17/19
06:59
Initiation
Jones Lang LaSalle initiated  »

Jones Lang LaSalle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 06

    Aug

USB

U.S. Bancorp

$53.04

-0.07 (-0.13%)

06:58
07/17/19
07/17
06:58
07/17/19
06:58
Hot Stocks
U.S. Bancorp CEO says 'We delivered strong results this quarter' »

Andy Cecere, Chairman,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

KBH

KB Home

$26.74

0.42 (1.60%)

06:58
07/17/19
07/17
06:58
07/17/19
06:58
Upgrade
KB Home rating change  »

KB Home upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.99

-0.23 (-0.79%)

06:58
07/17/19
07/17
06:58
07/17/19
06:58
Hot Stocks
Bank of America says plans to return $37B of capital over next four quarters »

Bank of America, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

  • 06

    Sep

CMA

Comerica

$71.75

0.39 (0.55%)

06:58
07/17/19
07/17
06:58
07/17/19
06:58
Earnings
Comerica reports Q2 EPS $1.94, consensus $2.00 »

Reports Q2 CET1 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

SWX

Southwest Gas

$89.37

-0.235 (-0.26%)

06:57
07/17/19
07/17
06:57
07/17/19
06:57
Initiation
Southwest Gas initiated  »

Southwest Gas initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.99

-0.23 (-0.79%)

06:56
07/17/19
07/17
06:56
07/17/19
06:56
Hot Stocks
Bank of America reports Q2 CET1 ratio 11.7% »

Says Assets Under…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

  • 06

    Sep

SLGN

Silgan Holdings

$30.38

0.17 (0.56%)

06:56
07/17/19
07/17
06:56
07/17/19
06:56
Upgrade
Silgan Holdings rating change  »

Silgan Holdings upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.